Ishikawa M, Shibata T, Iwata T, Nishio S, et al. A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Prim Gynecol Oncol 2021 May 17. pii: S0090-8258(21)00403.
PMID: 34016453